Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Top Cited Papers
- 1 March 2020
- journal article
- research article
- Published by Elsevier BV in Travel Medicine and Infectious Disease
- Vol. 34, 101663
- https://doi.org/10.1016/j.tmaid.2020.101663
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de la Recherche
This publication has 23 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBioScience Trends, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- Chloroquine for the 2019 novel coronavirus SARS-CoV-2International Journal of Antimicrobial Agents, 2020
- Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, ChinaIntensive Care Medicine, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the LiteratureDrug Safety, 2018
- U.S. Outpatient Antibiotic Prescribing, 2010The New England Journal of Medicine, 2013